These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20803561)

  • 21. Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study.
    Ikezaki H; Furusyo N; Hiramine S; Ura K; Mitsumoto-Kaseida F; Takayama K; Shimizu M; Toyoda K; Ogawa E; Kainuma M; Murata M; Hayashi J
    Arch Virol; 2016 Mar; 161(3):641-8. PubMed ID: 26660164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C.
    Jiménez-Sousa MA; Fernández-Rodríguez A; Guzmán-Fulgencio M; García-Álvarez M; Resino S
    BMC Med; 2013 Jan; 11():6. PubMed ID: 23298311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between genetic variations and serum level of interleukin 28B with virus genotypes and disease progression in chronic hepatitis C virus infection.
    Al-Qahtani A; Al-Anazi M; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khan MQ; Albenmousa A; Khalaf N; Viswan N; Al-Ahdal MN
    J Immunol Res; 2015; 2015():768470. PubMed ID: 25811035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Favourable' IL28B polymorphisms are associated with a marked increase in baseline viral load in hepatitis C virus subtype 3a infection and do not predict a sustained virological response after 24 weeks of therapy.
    Bucci C; von Delft A; Christian A; Flemming VM; Harrison A; Halliday J; Collier J; Manganis C; Klenerman P; Irving W; Barnes E
    J Gen Virol; 2013 Jun; 94(Pt 6):1259-1265. PubMed ID: 23486666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-28B genetic variations and spontaneous clearance of hepatitis C antibody-positive blood donors in China.
    Liu Y; Ma H; Chen S; Wang J; Liu G; Xu M; Ke L; He M
    Transfusion; 2013 Oct; 53(10 Pt 2):2498-504. PubMed ID: 23782163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Interleukin 28B Polymorphism with Clearance of Hepatitis C Virus: A Mini Review.
    Shaheen M; Afzal S; Khubaib B; Amin I; Shahid M; Idrees M
    Crit Rev Eukaryot Gene Expr; 2020; 30(3):223-229. PubMed ID: 32749108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 28B polymorphisms as predictor of response in hepatitis C virus genotype 2 and 3 infected patients.
    Mangia A; Mottola L; Santoro R
    World J Gastroenterol; 2013 Dec; 19(47):8924-8. PubMed ID: 24379617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel.
    Maor Y; Morali G; Bashari D; Pénaranda G; Schapiro JM; Martinowitz U; Halfon P
    Haemophilia; 2013 Jan; 19(1):150-6. PubMed ID: 22913807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum level of IP-10 increases predictive value of IL28B polymorphisms for spontaneous clearance of acute HCV infection.
    Beinhardt S; Aberle JH; Strasser M; Dulic-Lakovic E; Maieron A; Kreil A; Rutter K; Staettermayer AF; Datz C; Scherzer TM; Strassl R; Bischof M; Stauber R; Bodlaj G; Laferl H; Holzmann H; Steindl-Munda P; Ferenci P; Hofer H
    Gastroenterology; 2012 Jan; 142(1):78-85.e2. PubMed ID: 22192885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
    Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD
    Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients.
    Sticchi L; Di Biagio A; Sartini M; Rappazzo E; Nicolini LA; Cenderello G; Valle C; Azzola E; Grasso A; De Leo P; Boldrini A; Setti M; Prinapori R; Lorusso C; Bruzzone B; Icardi G;
    New Microbiol; 2015 Oct; 38(4):499-509. PubMed ID: 26485009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of IL28B and MxA gene polymorphisms on HCV clearance in Han Chinese population.
    Zang F; Yue M; Yao Y; Liu M; Fan H; Feng Y; Xia X; Huang P; Yu R
    Epidemiol Infect; 2018 Feb; 146(3):379-385. PubMed ID: 29271328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.
    Rallón NI; Naggie S; Benito JM; Medrano J; Restrepo C; Goldstein D; Shianna KV; Vispo E; Thompson A; McHutchison J; Soriano V
    AIDS; 2010 May; 24(8):F23-9. PubMed ID: 20389235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population.
    Shi X; Pan Y; Wang M; Wang D; Li W; Jiang T; Zhang P; Chi X; Jiang Y; Gao Y; Zhong J; Sun B; Xu D; Jiang J; Niu J
    PLoS One; 2012; 7(5):e37054. PubMed ID: 22649509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis C.
    Bellanti F; Vendemiale G; Altomare E; Serviddio G
    Clin Dev Immunol; 2012; 2012():849373. PubMed ID: 22966241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.
    Tillmann HL; Thompson AJ; Patel K; Wiese M; Tenckhoff H; Nischalke HD; Lokhnygina Y; Kullig U; Göbel U; Capka E; Wiegand J; Schiefke I; Güthoff W; Grüngreiff K; König I; Spengler U; McCarthy J; Shianna KV; Goldstein DB; McHutchison JG; Timm J; Nattermann J;
    Gastroenterology; 2010 Nov; 139(5):1586-92, 1592.e1. PubMed ID: 20637200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.
    Mangia A; Thompson AJ; Santoro R; Piazzolla V; Tillmann HL; Patel K; Shianna KV; Mottola L; Petruzzellis D; Bacca D; Carretta V; Minerva N; Goldstein DB; McHutchison JG
    Gastroenterology; 2010 Sep; 139(3):821-7, 827.e1. PubMed ID: 20621700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL28B single nucleotide polymorphisms in the treatment of hepatitis C.
    Lange CM; Zeuzem S
    J Hepatol; 2011 Sep; 55(3):692-701. PubMed ID: 21440591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4.
    Antaki N; Bibert S; Kebbewar K; Asaad F; Baroudi O; Alideeb S; Hadad M; Abboud D; Sabah H; Bochud PY; Negro F
    J Viral Hepat; 2013 Jan; 20(1):59-64. PubMed ID: 23231085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1.
    Ogawa E; Furusyo N; Murata M; Ikezaki H; Ihara T; Hayashi T; Toyoda K; Taniai H; Okada K; Kainuma M; Hayashi J
    J Hepatol; 2012 Sep; 57(3):534-40. PubMed ID: 22613000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.